Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

10.33
BATS BZX Real-Time Price
As of 11:38am ET
 +0.33 / +3.30%
Today’s Change
8.27
Today|||52-Week Range
23.35
-35.52%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close10.00
Today’s open10.08
Day’s range10.08 - 10.37
Volume3,328
Average volume (3 months)347,644
Market cap$572.2M
Dividend yield--
Data as of 11:38am ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)+33.91%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...+0.68+4.60%
PDLIPDL BioPharma Inc+0.06+1.56%
LOXOLoxo Oncology Inc+0.26+1.03%
CLVSClovis Oncology Inc+0.27+1.93%
Data as of 11:40am ET, 07/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs